GRAFAPEX 1000 mg/g
treosulfan · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Medexus Pharma, Inc.
Grafapex (treosulfan) is an intravenous chemotherapy medication used to prepare the body for bone marrow or stem cell transplantation. It works by destroying cancer cells and bone marrow cells to make room for transplanted healthy cells.
Key Facts
- Brand Name
- GRAFAPEX
- Generic Name
- treosulfan
- NDC Code (Product)
59137-335- Manufacturer
- Medexus Pharma, Inc.
- Strength
- 1000 mg/g
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA214759
- Marketing Start
- 01/28/2025
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is GRAFAPEX used for?
Grafapex (treosulfan) is an intravenous chemotherapy medication used to prepare the body for bone marrow or stem cell transplantation. It works by destroying cancer cells and bone marrow cells to make room for transplanted healthy cells.
Is GRAFAPEX a controlled substance?
GRAFAPEX is not classified as a controlled substance by the DEA.
What is the generic name for GRAFAPEX?
The generic name for GRAFAPEX is treosulfan. There are no other listed brand versions of treosulfan.
What is the NDC code for GRAFAPEX 1000 mg/g?
The NDC (National Drug Code) for GRAFAPEX 1000 mg/g is 59137-335, listed by Medexus Pharma, Inc..
Other GRAFAPEX Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)